Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Safety and Efficacy of Eltrombopag in Patients Undergoing Cord Blood or Haploidentical Bone Marrow Transplantation

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01927731
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:49.235148+00:00
Published At
2024-04-23T00:00:00+00:00
Record Updated At
2024-04-23
Results Posted At
2024-04-23
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Bone Marrow Transplantation Recipient", "Cord Blood Transplant Recipient", "Hematopoietic Cell Transplantation Recipient"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-04-23"
protocolSection.identificationModule.nctId
"NCT01927731"
protocolSection.identificationModule.officialTitle
"Safety and Efficacy of Eltrombopag in Patients Undergoing Cord Blood or Haploidentical Bone Marrow Transplantation"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2024-04-23"

Study condition terms

  • Bone Marrow Transplantation Recipient (protocolSection.conditionsModule.conditions)
  • Cord Blood Transplant Recipient (protocolSection.conditionsModule.conditions)
  • Hematopoietic Cell Transplantation Recipient (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.